The University of Connecticut School of Pharmacy,
Office of Pharmacy Professional Development
and the CT Chapter of the American Society of Consultant Pharmacists present:
The 2nd Annual Schwarting Senior Symposium
Tuesday, March 17th 2015
6:30am – 5:00pm
Aqua Turf Club
556 Mulberry St.
Plantsville, CT
Senior Symposium – Track #1
Arthur E. Schwarting Pharmacy Practice Symposium
MTM for Patients with Diabetes – Track #2
Immunization Training for Pharmacists – Track #3
Senior Symposium – Track #1
A full day symposium for pharmacists and nurse practitioners involved in geriatric care.
This program has been submitted to the American Association of Nurse Practitioners.
Initial Release Date: March 17, 2015
6:30 – 7:00 am
Registration
7:00 – 8:00 am
Estimating Renal Function in Elderly Patients and Implications for Medication
Management
Rachel Eyler, PharmD, BCPS; Assistant Clinical Professor of Pharmacy Practice, University of Connecticut
School of Pharmacy
Contact Hours: 1
At the completion of this activity, the participant will be able to:
1. Describe the pathophysiology of the failing kidney.
2. Review commonly used methods for evaluating renal function and determine clinical relevance
for dosing medications.
3. Identify general approaches for optimizing pharmacokinetics in patients with CKD (including
dialysis patients).
4. Identify potentially overlooked medications that may require dose adjustments.
5. Review other pharmacotherapy-related issues for patients with aging kidneys.
UAN 0009-9999-15-008-L01-P (knowledge-based)
8:00 – 9:00 am
Breakfast Product Theater – Sponsor: Actavis
9:00 – 10:45 am
COPD: Tackling the Transition
10:45 – 11:45 am
Exhibit Hall
11:45 – 12:45 pm
Understanding CMS Ratings and the Pharmacist’s Role
Erika Cappelluti, MD, PhD, FCCP, ABIHM: The Center for Integrative Healthcare & Healing
Jeanne Reardon, APRN; Pulmonary Clinical Nurse Specialist, Hartford Hospital
Corinne Ewing, PharmD; Assistant Professor, University of Saint Joseph School of Pharmacy
Contact Hours: 1.75
At the completion of this activity, the participant will be able to:
1. Discuss common medication errors that occur during transitions of care across the continuum.
2. Define common psycho-social and economic factors impacting adherence with pulmonary
medications post-hospital stay.
3. Explain methods to optimize medication use to prevent COPD readmissions.
4. Discuss initial and maintenance dosing of inhaled medications.
5. Review new inhaled medications and discuss possible adverse events for these products.
6. Describe proper technique for administering inhaled medications.
7. Describe a multidisciplinary approach to inpatient care for COPD patients.
8. Describe the benefits of a Med to Bed process for COPD discharges.
UAN 0009-9999-15-009-L01-P (knowledge-based)
Jeanne Manzi, PharmD, CGP, FASCP; Clinical Advisor, CVS Health
Contact Hours: 1 (Law)
At the completion of this activity, the participant will be able to:
1. Discuss the CMS STAR rating system, why it was created and how it works.
2. Describe the differences between STAR measures for nursing homes and Medicare D plans.
3. List the rating measures for both nursing homes and plans that can be affected by consultant and
dispensing pharmacists.
4. Identify initiatives that pharmacists can implement to assist with improving STAR ratings for
nursing homes and plans.
UAN 0009-9999-15-010-L03-P (knowledge-based)
12:45 – 2:15pm
Lunch Product Theater – Sponsor: Novo Nordisk
2:15 – 3:45 pm
New Drug Update
3:45 – 4:00 pm
Break in Exhibit Hall Area
4:00 – 5:00 pm
Adverse Drug Events in the Elderly: An Update for 2015
Stephanie Hattoy, PharmD, BCPS, CGP; Assistant Professor, University of Saint Joseph School of Pharmacy
Christine Eisenhower, PharmD, BCPS; Clinical Assistant Professor of Pharmacy, University of Rhode Island
Contact Hours: 1.5
At the completion of this activity, the participant will be able to:
1. List indications, mechanisms of action, dosing, and adverse/side effects of new drug products.
2. Describe the potential place in therapy for each of the new drugs discussed.
3. Discuss the potential social or economic implications associated with each of the new drugs
discussed.
UAN 0009-9999-15-011-L01-P (knowledge-based)
Dennis Chapron, MS, RPh; Medication Safety Pharmacist, St. Francis Hospital & Medical Center
Contact Hours: 1
At the completion of this activity, the participant will be able to:
1. Discuss some recent reports and reviews on drug-induced acute kidney injury and electrolyte
abnormalities.
2. Discuss various aspects of drug-induced gastrointestinal injury including (a) risks associated with
monotherapy vs combination therapy, (b) the spectrum of injury and (c) the role of proton pump
inhibitors in influencing sites of bleeding (upper vs lower).
3. Describe the epidemiology of drug-induced hepatotoxicity with particular attention to
therapeutic classes involved, acute vs chronic effects, and locus of liver injury.
4. Discuss some recently reported drug-drug interactions.
UAN 0009-9999-15-012-L05-P (knowledge-based)
There is no grant funding for this activity.
None of the speakers listed above have any actual or potential conflicts of interest associated with their CPE presentation.
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of
continuing pharmacy education. 6.25 contact hours (0.625 CEU) will be awarded based on full session participation and completed online
evaluations.
Arthur E. Schwarting Pharmacy Practice Symposium – Track #2
Medication Therapy Management for Patients with Diabetes
A practice-based continuing education activity for pharmacists in all areas of practice who wish to further their clinical and
communication skills in the management of patients with diabetes to improve diabetes disease management and empower
patients with diabetes to improve their health.
Online Initial Release Date: September 10, 2012
Live Activity Initial Release Date: May 22, 2013
7:15 –7:50 am
Registration & Breakfast
7:50 – 8:00 am
Opening Remarks
8:00 – 10:00 am
Communication Skills Development for Health Behavior Change in Diabetes Management
10:00 – 10:45 am
Break in Exhibit Hall Area
10:45 – 12:45 pm
Communication Skills Development for Health Behavior Change in Diabetes Management
(continued)
12:45 – 1:45pm
Lunch Product Theater – Sponsor: Novo Nordisk
1:45 – 2:45 pm
Diabetes Guidelines and Medication Update
Jill Fitzgerald, PharmD; Director, Office of Pharmacy Professional Development, Associate Clinical Professor;
University of Connecticut School of Pharmacy
Devra Dang, PharmD, BCPS, CDE; Associate Clinical Professor, University of Connecticut School of Pharmacy
Stefanie Nigro, PharmD, BCACP, BC-ADM; Assistant Clinical Professor, MCPHS University
Marissa Salvo, PharmD; Assistant Clinical Professor, University of Connecticut School of Pharmacy
Contact Hours: 4
At the completion of this activity, the participant will be able to:
1. Identify how motivational interviewing (MI) differs from our everyday mode of
persuading/motivating patients.
2. Describe the MI communication “tools” that can be used to explore patient resistance and
ambivalence.
3. Apply motivational interviewing skills in small group written activities for a diabetes disease
management conversation with a non-adherent patient.
4. Apply MI skills in small group role-play activities for case scenario exercises regarding
comprehensive diabetes disease management and health behavior change.
UAN 0009-9999-13-054-L04-P (application-based)
Devra Dang, PharmD, BCPS, CDE; Associate Clinical Professor, University of Connecticut School of Pharmacy
Contact Hours: 1
At the completion of this activity, the participant will be able to:
1. Describe the changes to the management of diabetes recommended by the 2013 American
Diabetes Association’s Standards of Medical Care in Diabetes.
2. Summarize the 2013 American Association of Clinical Endocrinologists (AACE) Comprehensive
Diabetes Management Algorithm.
3. Compare and contrast recently-approved medications for glycemic control.
UAN 0009-9999-13-074-L01-P (application-based)
2:45 – 3:45 pm
Application of MTM Concepts to the Patient with Diabetes – Case Discussion
3:45 – 4:00 pm
Break in Exhibit Hall Area
4:00 – 5:00 pm
Application of MTM Concepts to the Patient with Diabetes – Case Discussion (continued)
Devra Dang, PharmD, BCPS, CDE; Associate Clinical Professor, University of Connecticut School of Pharmacy
Stefanie Nigro, PharmD, BCACP, BC-ADM; Assistant Clinical Professor, MCPHS University
Marissa Salvo, PharmD; Assistant Clinical Professor, University of Connecticut School of Pharmacy
Contact Hours: 2
At the completion of this activity, the participant will be able to:
1. Perform a medication therapy review for a patient with diabetes.
2. Create a personal medication record.
3. Create a patient medication-related action plan.
4. Identify medication-related issues that require intervention on the part of the pharmacist to the
provider.
5. Document the MTM encounter.
UAN 0009-9999-13-055-L01-P (application-based)
Pre-requisite Activities:
All participants in the live sessions must complete the following prior to attending the session:
 All seven (7) Drug Topics (September 2012 – March 2013) knowledge-based journal articles must be completed for CE
credits http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/mtm-for-patients-with-dm/
 All three (3) Drug Topics application-based interactive case studies (February 2013-April 2013) must be completed for CE
Credits http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/mtm-for-patients-with-dm/
Post Activity Requirements:
To be awarded a Certificate of Achievement in MTM for Patients with Diabetes, all participants must complete the Post Activity
Requirements:
MTM Encounters with Patients
 Perform initial MTM encounters with 3 patients
 Perform follow up MTM encounters with 3 patients
 Complete and submit documentation of patient encounters
Description and instruction will be provided at the live event
UAN 0009-9999-13-056-H01-P (application-based)
Maximum number of participants: 50
As of December 10, 2014 we have not received any funding for the live event.
Grant funding for the home study material and the development of the live event materials is disclosed on the website and in the printed materials.
None of the speakers listed above have any actual or potential conflicts of interest associated with their CPE presentation.
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of
continuing pharmacy education. Statements of Credit for the live event (7 contact hours (0.7 CEU) will be awarded based on full session
participation and completed evaluations.
A Certificate of Achievement for MTM for Patients with Diabetes and an additional 6 contact hours (0.6 CEU) will be awarded based on full
participation and completion of the post-activity requirements. (0009-0006)
Immunization Training for Pharmacists – Track #3
This comprehensive practice-based continuing pharmacy education program is designed to meet state regulations for
pharmacist immunizers.
Online initial release date: August 27, 2012
Live program: Initial release date: September 22, 2012
Faculty
Thomas Buckley, BS, MPH: Assistant Clinical Professor of Pharmacy Practice, University of Connecticut School of Pharmacy
Jennifer Girotto, PharmD, BCPS: Associate Clinical Professor of Pharmacy Practice, University of Connecticut School of Pharmacy
Jill Fitzgerald, PharmD: Director, Pharmacy Professional Development and Associate Clinical Professor of Pharmacy Practice,
University of Connecticut School of Pharmacy
Contact Hours: 20
At the end of the activities, pharmacists will be able to:
1. Describe the diseases that each vaccine in the schedules prevent.
2. Describe differences between conjugate and polysaccharide vaccines as well as live and inactivated vaccines.
3. List disease states or patient characteristics for which live vaccines are contraindicated.
4. List currently recommended routine vaccines and their mechanism of action, contraindications, precautions, drug
interactions and monitoring after administration.
5. List common and known serious adverse events from vaccines in the current schedules.
6. Describe what Vaccine Adverse Event Reporting System (VAERS) is and the mechanism to report adverse events.
7. Explain the impact of vaccination on public health.
8. Identify community resources and immunization coalitions available.
9. Describe the pharmacist’s role as an advocate for immunization.
10. Describe Occupational Safety and Health Administration (OSHA) regulations to protect employees from bloodborne pathogens.
11. Recall proper biohazard waste disposal and sterile techniques.
12. Describe the proper immunization screening, vaccine information sheets, informed consent, record keeping and
registries pharmacists would use in an immunization program.
13. Identify storage requirements for vaccines.
14. Identify strategies for maintaining competency for vaccinations.
15. Apply strategies for prevention and management of errors related to vaccinations.
16. Apply patient engagement strategies for various immunization scenarios.
17. Identify risk factors for immunization of specific patient populations.
18. Apply health literacy tools to assist in identification and resolution of barriers for vaccination of specific patient
populations.
19. Identify best practices for patient immunization reminders.
20. Review ACIP pediatric and adult routine vaccination schedules.
21. Apply current vaccine schedules to specific patient cases.
22. Describe various administration techniques for vaccines (e.g. intranasal, intradermal).
23. Demonstrate how to give a subcutaneous and intramuscular injection.
24. Explain current reimbursement procedures and vaccine coverage by federal, state and local entities.
25. Describe the current state laws governing the administration of vaccines by pharmacists.
26. Explain how to develop protocols or standing orders for vaccines.
7:15 – 8:00 am
Registration & Breakfast
8:00 – 10:00 am
Immunization Update and Schedule Workshop
10:00 – 10:45 am
Break in Exhibit Hall Area
10:45 – 12:45 pm
Identifying Appropriate Strategies for Pharmacist Vaccinations
UAN 0009-0000-12-079-L01-P
UAN 0009-0000-12-078-L01-P
12:45 – 1:45pm
Lunch Product Theater – Sponsor: Novo Nordisk
1:45 – 2:45 pm
Administration Technique Workshop
2:45 – 3:45 pm
Prevention and Management of Vaccination Errors
3:45 – 4:00 pm
Break in Exhibit Hall Area
4:00 – 5:00 pm
Legal and Practical Considerations for Pharmacist Immunizers
UAN 0009-0000-12-080-L01-P
UAN 0009-0000-12-077-L01-P
UAN 0009-0000-12-081-L03-P
Maximum number of participants: 30
There is no grant funding for this activity.
None of the speakers listed above have any actual or potential conflicts of interest associated with their CPE presentation.
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of
continuing pharmacy education and will award a total of 20 contact hours (2.0 CEU’s) for pharmacists who successfully complete with a 70% passing
grade on all post tests for the online content, present all statements of completion for the online content, participate in the live session, pass the
workshop requirements and practical exam and complete a course evaluation.
13 knowledge-based contact hours (1.3 CEU) of home study credit (ACPE #009-0000-12-076-H01-P)
6 application-based contact hours (0.6 CEU) of live credit (ACPE # 009-0000-12-077-L01-P, 009-0000-12-078-L01-P, 009-0000-12-079-L01-P, and
009-0000-12-080-L01-P.
1 knowledge-based contact hour (0.1 CEU) of live credit (ACPE #009-0000-12-081-L03-P), will apply to law.
A Practice-based Certificate of Achievement will be presented following successful completion of all requirements. This activity meets state
requirements for immunization in Connecticut (with current CPR certification). For out of state participants please check your state regulations.
Registration Form (please print clearly as credits and certificates will be sent with this information) or
Pharmacists may register online at https://web2.uconn.edu/pharmacyce/program_register.php
Name & Credentials
Email
Home/Cell/Business Phone
Company/Organization
Home Address
City
State
Zip
For pharmacists only:
NABP e-Profile ID
DOB (MMDD)
Please let us know if you require special services due to a disability or dietary restriction
Track #1
Senior Symposium (SS) Registration Fee: $99 (until 3/1/15)
Senior Symposium (SS) Registration Fee: $129 (after 3/1/15)
SS: Students, residents, preceptor, and volunteers: $49.50
Track #2
MTM for Patients with Diabetes: $199
Track #3
Immunization Training for Pharmacists: $249
Sponsor a Student: $49.50
The registration fee, less a $50 processing fee, is refundable for those that cancel their registration 3 days prior to the
program. After that time, no refund is available.
All on site registrations will be assessed a $30 walk-in fee.
Please indicate your affiliation:
☐ Pharmacist
☐ Nurse
☐ Physician
☐ Other
Method of Payment:
☐ Enclosed is a check or money order payable to UCONN and sent to:
University of CT School of Pharmacy
ATTN: Joanne Nault
69 N Eagleville Rd, Unit 3092
Storrs, CT 06269
☐ Mastercard
☐ Visa
☐ Discover
Credit Card Number
Exp. Date (MM/YY)
Name (exactly as it appears on card)
Credit Card Billing Address
City
State
Zip
Security Code (CV)